INFO RE STATUS OF E4 IN MENOPAUSE/POST MENOPAUSE.
Does any one know how Mithra is proceeding re the said drug/drugs
re the said condition re trials .listings whatever.
Market for post menopausal drugs in USA is 3 times that of OC.
My guess is that Mithra may not be too far behind re that Vs OC listings
as they would have known from the very start the benefits in menopause.
Any info re this will be highly appreciated.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$5.06 |
Change
-0.010(0.20%) |
Mkt cap ! $409.4M | |||
| Open | High | Low | Value | Volume |
| $5.05 | $5.08 | $5.02 | $306.3K | 60.69K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 16138 | $5.04 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.05 | 919 | 10 |
View Market Depth
| Last trade - 14.52pm 07/08/2025 (20 minute delay) ? |
| MYX (ASX) Chart |